Abed Agbarya Selected Research

Abed Agbarya Research Topics

Disease

26	Neoplasms (Cancer) 03/2024 - 01/2014
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 03/2013
5	COVID-19 02/2024 - 01/2021
4	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2021
4	Lung Neoplasms (Lung Cancer) 08/2021 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 03/2024 - 01/2013
2	Adenocarcinoma 10/2023 - 01/2022
2	Disease Progression 03/2023 - 01/2021
2	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
2	Infections 01/2023 - 08/2021
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 10/2022
1	Ascites 03/2024
1	Breakthrough Infections 02/2024
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Exanthema (Rash) 01/2023
1	Hypesthesia (Numbness) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Pain (Aches) 01/2023
1	Pruritus (Itching) 01/2023
1	Colorectal Neoplasms (Colorectal Cancer) 01/2023
1	Myoepithelioma 01/2022
1	Chronic Disease (Chronic Diseases) 08/2021
1	Philadelphia Chromosome 08/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2021
1	Leukemia 08/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 08/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Encephalitis (Encephalitis, Rasmussen) 01/2021
1	Thrombophilia 02/2020
1	Microsatellite Instability 01/2018
1	Pneumonia (Pneumonitis) 08/2015
1	Pulmonary Edema 08/2015
1	Rectal Neoplasms (Rectal Cancer) 08/2015
1	Urinary Retention 08/2015
1	Carcinoma (Carcinomatosis) 01/2014

Drug/Important Bio-Agent (IBA)

5	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2021
4	VaccinesIBA 02/2024 - 08/2021
3	BNT162 VaccineIBA 09/2023 - 01/2021
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 08/2021
3	Tyrosine Kinase InhibitorsIBA 04/2022 - 08/2021
3	alectinibIBA 01/2022 - 01/2021
2	NivolumabIBA 08/2023 - 01/2021
2	Tumor Biomarkers (Tumor Markers)IBA 01/2023 - 01/2021
2	taxaneIBA 01/2023 - 10/2022
2	B7-H1 AntigenIBA 01/2023 - 01/2018
2	AndrogensIBA 01/2022 - 01/2014
2	CrizotinibIBA 01/2022 - 08/2021
2	Anaplastic Lymphoma KinaseIBA 12/2021 - 01/2021
2	Messenger RNA (mRNA)IBA 08/2021 - 01/2021
2	COVID-19 VaccinesIBA 08/2021 - 01/2021
2	Phosphotransferases (Kinase)IBA 08/2021 - 01/2021
1	PlatinumIBA 03/2024
1	CytokinesIBA 03/2024
1	ProteomeIBA 03/2024
1	IpilimumabIBA 08/2023
1	GastrinsIBA 03/2023
1	Chromogranin AIBA 03/2023
1	Minichromosome Maintenance ProteinsIBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2023
1	Neuropilin-1IBA 01/2023
1	MetallothioneinIBA 01/2023
1	Panitumumab (Vectibix)FDA Link 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	bicalutamide (Casodex)FDA LinkGeneric 01/2022
1	Alkaline PhosphataseIBA 12/2021
1	Immunoglobulin G (IgG)IBA 08/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	CitrullineIBA 01/2021
1	Tissue Kallikreins (Tissue Kallikrein)IBA 01/2021
1	OsteopontinIBA 01/2021
1	durvalumabIBA 01/2021
1	AntibodiesIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	EnzymesIBA 01/2021
1	human KLK3 proteinIBA 01/2021
1	atezolizumabIBA 11/2020
1	pembrolizumabIBA 11/2020
1	Heparin (Liquaemin)FDA LinkGeneric 02/2020
1	heparanaseIBA 02/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	Hormones (Hormone)IBA 01/2014

Therapy/Procedure

14	Therapeutics 03/2024 - 01/2014
7	Drug Therapy (Chemotherapy) 03/2024 - 03/2013
4	Immunotherapy 03/2024 - 11/2020
3	Radiotherapy 09/2021 - 01/2021
3	Complementary Therapies (Alternative Medicine) 01/2017 - 05/2015
1	Prostatectomy (Retropubic Prostatectomy) 10/2023
1	Acupuncture Therapy 01/2023
1	Integrative Oncology 01/2023
1	Withholding Treatment 01/2023
1	Adjuvant Chemotherapy 11/2021
1	Precision Medicine 01/2021
1	Palliative Care (Palliative Therapy) 07/2020
1	Catheters 08/2015
1	Neoadjuvant Therapy 08/2015
1	Musculoskeletal Manipulations (Manipulative Therapy) 05/2015
1	Homeopathy 05/2015
1	Traditional Medicine (Folk Remedies) 01/2015